(Total Views: 527)
Posted On: 03/06/2021 1:02:10 AM
Post# of 153898
The speculation and released data can intertwine to become a bit confusing, so bear with me, I'm not certain about this.
We reduced death in critical patients by 24%.
Overall death reduction could be greater than 24%.
Surely, leronlimab prevented some severe patients from advancing to critical and then dying. LL may have prevented 100% of the severe folks who were treated with LL, from dying. (All critical patients had to move thru severe to become critical).
.
If any of the approx 107 severe patients who got SOC, died, and if none or only a fewof the approx 214 severe folks who go LL died, this data would boost overall reduction of deaths above 24%.
We reduced death in critical patients by 24%.
Overall death reduction could be greater than 24%.
Surely, leronlimab prevented some severe patients from advancing to critical and then dying. LL may have prevented 100% of the severe folks who were treated with LL, from dying. (All critical patients had to move thru severe to become critical).
.
If any of the approx 107 severe patients who got SOC, died, and if none or only a fewof the approx 214 severe folks who go LL died, this data would boost overall reduction of deaths above 24%.
(5)
(0)
